We're excited to announce our new team member, Qasim Akhtar! Qasim is a recent Masters's graduate from the University of Manchester with a background in Biotechnology. Using his scientific background, combined with his experience in previously running consumer businesses, he'll help to drive forward the growth of the business as a Business Development Officer.
Co-Founder and Managing Director Chris Bullock will be joining the Alderley Park Accelerator, which will help provide the tools, methodologies, and approaches that will enable us to further grow the business
QV Bioelectronics has found a new home in Alderley Edge, Cheshire. We're excited to be moving into the Alderley Park Science Park, the UK's largest Bioscience campus. A centre renowned for its state of the art laboratory and workspace, better helping us to achieve our goals in developing innovative cancer therapies. Being part of a [...]
We have changed our name to one that better reflects our mission to develop innovative electrotherapies for cancer You can find us on Twitter @QVBio, on Linkedin, and on Medium @QVBio
The All-Party Parliamentary Group on Brain Tumours has released a report into the economic and social costs of brain tumours to the UK.
Honeycomb Biotechnology have been announced as the 2018 winners of the Eli and Britt Harari Award, a £50,000 cash prize awarded by the University of Manchester to develop commercially-viable ideas using the wonder material graphene.